Stocx Research Club logo ×
Screener Research Unlisted Startup Funding

Care Ratings

₹658.7 -1.1 | 0.2%

Market Cap ₹1953 Cr.

Stock P/E 22.5

P/B 2.9

Current Price ₹658.7

Book Value ₹ 229.1

Face Value 10

52W High ₹698.5

Dividend Yield 2.58%

52W Low ₹ 403

Overview Inc. Year: 1993Industry: Ratings

CARE Ratings Ltd, a credit rating organization, presents diverse rating and grading services in India, Mauritius, and Nepal. The agency presents rating offerings for debt gadgets, inclusive of bonds, debentures, hybrid instruments, preference shares, fixed deposits, commercial papers and short-term debt applications, and certificate of deposits; and financial institution mortgage; financial region rating offerings, which cover banks, non-banking finance agencies, housing finance corporations, financial establishments, and so on.; structured finance ratings; coverage ratings; infrastructure quarter ratings; and public finance rating offerings that cover ratings of state authorities entities and urban infrastructure initiatives, as well as company governance ratings, project finance, and MLD valuation services. It offers corporate advisory, project evaluation and tracking, credit analytics, industry and company research, and due diligence and grading services, in addition to research and analytics to corporates, economic establishments, banks, and institutional traders. It was formerly known as Credit Analysis and Research Ltd and changed its name to CARE Ratings Ltd in June 2017. CARE Ratings Ltd become included in 1993 and is based in Mumbai, India.

Read More..

Care Ratings Share Price

| |

Volume
Price

Quarterly Price

Show Value Show %

Peer Comparison

Care Ratings Quarterly Results

#(Fig in Cr.) Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022
Net Sales 76 56 80 49 76 56 66 55 85 62
Other Income 8 8 6 7 6 7 7 8 8 12
Total Income 84 64 85 57 82 63 73 62 93 74
Total Expenditure 34 37 49 41 43 41 43 38 43 48
Operating Profit 50 26 36 16 39 22 30 24 50 25
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 2 2 2 2 2 2 2 2 3 3
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 48 24 34 14 37 20 27 21 48 23
Provision for Tax 12 5 8 2 10 5 4 7 13 6
Profit After Tax 36 19 26 12 27 15 23 14 35 16
Adjustments -0 -0 -0 -1 -0 -0 -0 -0 -1 -0
Profit After Adjustments 35 19 26 11 27 15 23 14 34 16
Adjusted Earnings Per Share 12 6.3 8.8 3.7 9 4.9 7.7 4.6 11.6 5.4

Care Ratings Profit & Loss

#(Fig in Cr.) Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 TTM
Net Sales 180 203 236 261 279 287 333 319 244 248 248 268
Other Income 28 29 36 44 9 34 25 30 31 31 27 35
Total Income 208 232 271 304 288 321 358 349 275 280 275 302
Total Expenditure 56 68 88 101 105 105 122 144 162 153 168 172
Operating Profit 152 163 183 203 183 216 236 205 113 127 107 129
Interest 0 0 0 1 0 0 0 0 1 1 0 0
Depreciation 2 3 3 5 4 3 3 3 8 8 8 10
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 150 160 181 197 178 212 233 202 104 119 99 119
Provision for Tax 42 47 51 59 59 65 71 64 21 28 22 30
Profit After Tax 108 114 130 138 120 148 162 138 83 91 77 88
Adjustments -0 -0 -0 0 0 0 0 -1 -1 -1 -2 -1
Profit After Adjustments 108 114 129 138 120 148 162 137 82 90 75 87
Adjusted Earnings Per Share 0 39.8 44.6 47.5 40.7 50.1 55.1 46.7 28 30.4 25.3 29.3

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 0% -8% -3% 3%
Operating Profit CAGR -16% -19% -13% -3%
PAT CAGR -15% -18% -12% -3%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 29% 35% -12% -2%
ROE Average 13% 15% 20% 26%
ROCE Average 16% 19% 27% 36%

Care Ratings Balance Sheet

#(Fig in Cr.) Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Shareholder's Funds 377 424 485 359 409 520 597 550 533 589 647
Minority's Interest 1 1 1 0 0 0 2 2 3 4 5
Borrowings 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 6 201 252 312 371 15 9 13 22 25 21
Total Current Liabilities 46 75 87 78 86 475 551 611 541 557 584
Total Liabilities 430 701 825 749 866 1010 1159 1177 1099 1175 1257
Fixed Assets 56 58 59 65 64 61 60 83 93 85 96
Other Non-Current Assets 107 348 447 501 593 83 257 252 229 40 65
Total Current Assets 266 295 319 184 209 866 842 842 777 1050 1096
Total Assets 430 701 825 749 866 1010 1159 1177 1099 1175 1257

Care Ratings Cash Flow

#(Fig in Cr.) Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Opening Cash & Cash Equivalents 18 70 27 25 13 12 13 24 20 7 12
Cash Flow from Operating Activities 98 83 107 107 106 119 134 109 67 86 68
Cash Flow from Investing Activities -7 -87 -46 157 -41 -22 -25 83 27 -38 -27
Cash Flow from Financing Activities -40 -40 -62 -276 -66 -96 -99 -195 -107 -43 -35
Net Cash Inflow / Outflow 51 -44 -1 -12 -1 1 11 -4 -13 5 6
Closing Cash & Cash Equivalent 70 27 25 13 12 13 24 20 7 12 18

Care Ratings Ratios

# Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Earnings Per Share (Rs) 0 39.78 44.62 47.53 40.68 50.13 55.13 46.66 27.96 30.38 25.33
CEPS(Rs) 38.45 40.95 45.72 49.28 42.1 51.27 56.17 47.99 30.97 33.52 28.51
DPS(Rs) 10 20 28 79 28 28 55 30 19.5 17 17
Book NAV/Share(Rs) 0 148.57 166.88 121.46 138.53 176.5 199.65 179.42 173.02 191.49 215.75
Core EBITDA Margin(%) 68.73 66.3 62.7 61.24 62.24 63.39 63.35 54.76 33.38 38.55 32.15
EBIT Margin(%) 83.31 78.91 76.65 76.06 63.86 73.93 70.06 63.24 43.1 48 40.02
Pre Tax Margin(%) 83.31 78.91 76.65 75.56 63.86 73.93 70.06 63.24 42.72 47.76 39.83
PAT Margin (%) 59.94 55.98 55.03 52.9 42.81 51.36 48.8 43.29 34.26 36.61 31.03
Cash Profit Margin (%) 61.13 57.58 56.27 54.85 44.31 52.54 49.74 44.33 37.45 39.75 34.14
ROA(%) 25.04 20.1 16.99 17.52 14.82 15.74 14.97 11.82 7.34 8 6.32
ROE(%) 28.54 28.37 28.55 32.96 31.49 31.85 29.3 24.73 16.08 16.94 12.76
ROCE(%) 39.66 39.98 39.7 46.94 46.48 45.76 41.74 35.18 19.39 21.26 16.03
Receivable days 32.46 34.35 28.7 21.39 25.71 31.06 35.4 49.49 66.03 45.73 28
Inventory Days 0 0 0 0 0 0 0 0 0 0 0
Payable days 0 0 0 0 0 0 0 0 0 0 0
PER(x) 0 20.13 17.37 31.07 22.92 33.06 21.96 21.18 11.79 13.53 20.21
Price/Book(x) 0 5.39 4.65 12.16 6.73 9.39 6.06 5.51 1.9 2.15 2.37
Dividend Yield(%) 0 2.5 3.61 5.35 3 1.69 4.54 3.04 5.92 4.13 3.32
EV/Net Sales(x) -0.23 11.12 9.42 16.38 9.77 16.93 10.63 9.03 3.51 3.71 5.8
EV/Core EBITDA(x) -0.27 13.81 12.09 21 14.94 22.54 14.98 14.05 7.59 7.25 13.45
Net Sales Growth(%) 0 13.06 16.04 10.6 7.22 2.89 15.74 -4.12 -23.62 1.97 -0.33
EBIT Growth(%) 0 7.1 12.7 9.74 -9.98 19.11 9.69 -13.45 -47.94 13.56 -16.91
PAT Growth(%) 0 5.6 14.06 6.3 -13.22 23.42 9.97 -14.95 -39.54 8.97 -15.54
EPS Growth(%) 0 0 12.18 6.5 -14.41 23.24 9.97 -15.36 -40.08 8.67 -16.62
Debt/Equity(x) 0 0 0 0 0 0 0 0 0 0 0
Current Ratio(x) 5.73 3.93 3.67 2.34 2.43 1.82 1.53 1.38 1.44 1.88 1.88
Quick Ratio(x) 5.73 3.93 3.67 2.34 2.43 1.82 1.53 1.38 1.44 1.88 1.88
Interest Cover(x) 0 0 0 152.53 0 0 0 0 113.23 193.14 213.66
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0 0 0 0

Care Ratings Shareholding Pattern

# Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022
Promoter 0 0 0 0 0 0 0 0 0 0
FII 27.65 26.3 22.69 23.52 21.13 23.18 25.74 17.47 18.13 17.99
DII 27.61 21.69 20.4 18.48 17.89 16.1 14.52 21.53 24.88 25.06
Public 44.74 52.01 56.91 58.01 60.98 60.72 59.74 61 56.99 56.94
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Care Ratings News